Three Ways Med Tech can Improve the Public Image of Pharma
For pharmaceutical companies, negative publicity is always a risk. The success of research, trials and the rollout of a product is dependent on the trust…
For pharmaceutical companies, negative publicity is always a risk. The success of research, trials and the rollout of a product is dependent on the trust…
A 2018 survey conducted by the UK agency Medicines Discovery Catapult found that 80% of SMEs (small to medium sized biotechs) found accessing biosamples from…
Today, we can enjoy innovations that were once considered science fiction, thanks to Data Science. Machine Learning (ML) and Artificial Intelligence (AI) have revolutionized the…
As the life sciences industry continues to embrace virtual interactions over the long term, digital is becoming more than just a way for field reps…
Top-level management from pharma companies and IT leaders from the manufacturing and packaging sector get together at Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2021) on…
The pressures on overstretched NHS resources are well documented and well understood. With increasing focus on better integrated and connected care in the community, especially…
“Nature abhors a vacuum,” and health technology assessment (HTA) bodies and payers hate uncertainty. Unfortunately, when it comes to advanced therapy medicinal products (ATMPs), they…
The cost of drug development totalled approximately one billion U.S. dollars in the decade from 1990 to 1999, but has more than doubled in the…
GPs and other NHS prescribers may have helped avoid tens of thousands of falls amongst the elderly after using prescribing decision technology FDB OptimiseRx to…
While COVID-19 undoubtedly brought great chaos and crises last year, it also fuelled incredible innovation and collaboration across the life sciences industry. We saw new…